Bovine viral diarrhoea virus (BVDV) is a pestivirus with worldwide distribution. Infections are common in New Zealand with an estimated 85% of herds infected. BVDV infection leads to a range of disease problems but reproductive failure is the principal cause of economic loss. The following trial was undertaken to determine if vaccination of sero-negative heifers with a multivalent viral vaccine containing a 1a BVD strain (NADL) was able to protect the foetus from infection with a field strain of BVDV.

About this article

Date

Sep 4, 2016

Summary

The results demonstrate that the use of Hiprabovis® BVD 1a strain in seronegative heifers provided significant protection against foetal infection when the herd was subsequently exposed to a high level of natural BVD challenge during gestation.

Related publications

Share this on

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar

BVD foetal protection by vaccination. Cattle

Display portlet menu
end portlet menu bar

See also